Cauda equina syndrome in horses, more accurately termed polyneuritis equi (PNE), is an uncommon but clinically significant neurological disease characterized by progressive granulomatous inflammation of the sacrococcygeal nerve roots and...
Overview and Clinical Importance
Cauda equina syndrome in horses, more accurately termed polyneuritis equi (PNE), is an uncommon but clinically significant neurological disease characterized by progressive granulomatous inflammation of the sacrococcygeal nerve roots and occasionally cranial nerves. First described by Dexler in 1897, this condition represents an immune-mediated polyneuropathy with pathologic similarities to Guillain-Barre syndrome in humans.
The term "cauda equina" derives from Latin meaning "horse's tail," referring to the bundle of spinal nerve roots extending from the caudal spinal cord. While this anatomical structure exists in all mammals, horses are highly susceptible to this specific inflammatory condition affecting these nerve roots.
High-YieldOn the NAVLE, polyneuritis equi (PNE) is the preferred terminology over "cauda equina neuritis" because cranial nerves are frequently affected beyond the cauda equina.
| Structure |
Description |
Clinical Significance |
| Conus Medullaris |
Tapered distal end of spinal cord at S2-S3 |
Contains sacral segments; lesions cause bilateral symmetric signs |
| Cauda Equina |
Bundle of L6-S5 and coccygeal nerve roots |
Primary site affected in PNE; innervates tail, perineum, bladder, rectum |
| Filum Terminale |
Fibrous band extending from conus to coccyx |
Anchors spinal cord; can be involved in inflammation |
| Lumbar Cistern |
CSF-filled subarachnoid space |
Site for lumbosacral CSF collection |
Anatomical Foundations
The Cauda Equina in Horses
In horses, the spinal cord terminates at the sacrococcygeal junction (S2-S3 level), forming the conus medullaris. Distal to this point, the lumbosacral and coccygeal spinal nerve roots continue within the vertebral canal as the cauda equina, suspended in cerebrospinal fluid within the lumbar cistern.
Key Anatomical Structures
Cauda Equina Nerve Root Functions
| Nerve Roots |
Motor Function |
Sensory Function |
| Sacral (S1-S5) |
Anal sphincter, bladder detrusor, urethral sphincter, tail muscles |
Perineum, caudal thigh, tail base |
| Coccygeal |
Coccygeal muscles, tail movement |
Tail sensation |
| Pudendal (S2-S4) |
External anal/urethral sphincters, penis retraction |
Perineum, external genitalia |
| Pelvic (S2-S4) |
Parasympathetic: bladder contraction, rectal motility |
Visceral sensation from pelvic organs |
Etiology and Pathogenesis
Proposed Immune-Mediated Mechanism
The exact etiology remains unknown, but strong evidence supports an immune-mediated pathogenesis. The disease shares similarities with Guillain-Barre syndrome in humans. The prevailing theory suggests autoimmunity against myelin P2 protein causes nerve fiber destruction.
Key pathogenic features:
- Anti-P2 myelin protein antibodies detected in affected horses
- T-lymphocyte and B-lymphocyte infiltration of affected nerves
- CD8+ cytotoxic T-cells predominate over CD4+ helper T-cells
- Primary demyelination progressing to granulomatous polyneuritis
Proposed Infectious Triggers
Pathologic Findings
Gross Pathology
- Thickened, firm extradural and intradural nerve roots of cauda equina
- Nerves may appear diffusely white or discolored by hemorrhage
- Marked muscle atrophy of sacrocaudalis dorsalis and ventralis
- Sabulous cystitis secondary to bladder atony
Histopathology
- Granulomatous neuritis with lymphocytes, macrophages, multinucleated giant cells
- Demyelination and axonal degeneration
- Epineurial, perineurial, and endoneurial fibrosis
| Agent |
Evidence |
Status |
| EHV-1 |
Isolated from some cases |
Not confirmed causative |
| Equine Adenovirus |
Isolated from cauda equina |
Bystander mechanism proposed |
| Streptococcus equi |
History of strangles in some cases |
Possible post-infectious trigger |
| Sarcocystis neurona |
Recent research suggests association |
Under investigation |
Epidemiology
| Factor |
Details |
| Species |
Horses and ponies of all breeds |
| Age |
Adults; rarely yearlings, NEVER foals |
| Sex |
No definitive predisposition; some reports suggest females |
| Breed |
No breed predisposition |
| Geography |
Reported in North America and Europe |
| Incidence |
Uncommon; true incidence unknown |
Clinical Signs
Disease Progression
PNE typically presents as a slowly progressive, chronic disease. Signs progress through characteristic phases:
Early Phase (Hyperesthesia): Tail rubbing, hypersensitivity to touch
Progressive Phase (Hypoesthesia): Decreased sensation progressing to analgesia
Late Phase (Paralysis): Complete paralysis of tail, anus, rectum, bladder
Cauda Equina Signs (Most Common)
Cranial Nerve Signs (Distinguishes PNE)
Cranial nerve involvement distinguishes "polyneuritis equi" from "cauda equina neuritis." Cranial signs are typically asymmetric, while caudal signs are symmetric.
NAVLE TipWhen you see symmetric cauda equina signs + asymmetric cranial nerve signs, think PNE immediately. This combination is the clinical hallmark.
| System |
Clinical Signs |
Mechanism |
| Tail |
Flaccid paralysis, absent tail tone |
Coccygeal nerve damage |
| Perineum |
Analgesia; loss of perineal reflex |
Pudendal nerve sensory loss |
| Bladder |
Urinary incontinence, dribbling, distension |
Pelvic nerve dysfunction |
| Rectum/Anus |
Fecal retention, hypotonic sphincter |
Pudendal and pelvic nerve damage |
| Male Reproductive |
Penile paralysis, prolapse |
Pudendal nerve motor loss |
| Hindquarters |
Gluteal atrophy, mild pelvic limb weakness |
Lumbosacral plexus extension |
Diagnosis
Polyneuritis equi is a diagnosis of exclusion. No definitive antemortem test exists; confirmation requires histopathology at necropsy.
Diagnostic Tests
High-YieldLumbosacral CSF collection is the most useful antemortem test. Xanthochromic CSF with elevated protein strongly supports PNE. Atlantooccipital CSF may be normal.
| Cranial Nerve |
Clinical Signs |
Frequency |
| CN VII (Facial) |
Facial paralysis, ear/lip droop, decreased tears |
Most common |
| CN VIII (Vestibulocochlear) |
Head tilt, nystagmus, vestibular ataxia |
Common |
| CN V (Trigeminal) |
Masseter atrophy, decreased facial sensation |
Less common |
| CN IX, X |
Dysphagia, difficulty swallowing |
Rare |
Differential Diagnosis
Exam Focus: Sacral fractures are MORE COMMON than PNE - always rule out first! PNE affects ADULTS (never foals) and is slowly progressive, while fractures are acute.
| Test |
Expected Findings |
Utility |
| Lumbosacral CSF |
Xanthochromia; protein 100-300 mg/dL; mixed pleocytosis |
Most useful antemortem test |
| Sacral Radiography |
Normal (rules out fracture) |
Essential to exclude trauma |
| Rectal Palpation |
Normal sacrum; distended bladder |
Rules out fracture; assesses complications |
| Ultrasonography |
Enlarged, hypoechoic nerve roots |
Supportive; visualizes thickened nerves |
| Muscle Biopsy |
Neurogenic atrophy; inflammatory infiltrates |
Supports antemortem diagnosis |
Treatment and Management
There is no effective curative treatment. Management is palliative.
| Differential |
Distinguishing Features |
Key Tests |
| Sacral Fracture |
Acute onset; history of trauma; MORE COMMON |
Rectal palpation; radiography |
| EPM |
Asymmetric ataxia; multifocal signs |
S. neurona serology/CSF |
| EHV-1 |
Acute; fever; multiple horses affected |
PCR nasal swab; serology |
| Sorghum Toxicosis |
History of sorghum pasture; cystitis |
History; remove from pasture |
| Rabies |
Progressive; behavioral changes; ALWAYS consider |
Postmortem brain FA |
Prognosis
The prognosis is POOR to GRAVE. Disease is slowly progressive and irreversible. Most horses are euthanized.
- Disease progression is relentless despite treatment
- Corticosteroids provide only temporary, short-lived improvement
- Secondary complications significantly impact quality of life
- Euthanasia typically recommended within weeks to months
High-YieldOn NAVLE questions, "poor prognosis" or "euthanasia" is almost always correct regarding PNE outcome.
| Treatment |
Protocol |
Notes |
| Corticosteroids |
Dexamethasone 0.1-0.2 mg/kg IV/IM; taper |
Short-lived benefit; monitor for laminitis |
| Bladder Management |
Manual expression 2-3x daily; treat UTI |
Prevent overdistension; culture urine |
| Fecal Management |
Manual evacuation; dietary management |
Monitor for colic; hydration |
| Skin Care |
Clean/dry perineum; barrier creams |
Prevents urine scald dermatitis |
Memory Aids
"CAUDA" Mnemonic
C - Coccygeal/tail paralysis
A - Anal sphincter hypotonia
U - Urinary incontinence
D - Dysesthesia/anesthesia (perineal)
A - Atrophy (gluteal and tail muscles)
Key Diagnostic Clues
"Adult horse + Progressive tail/perineal paralysis + NO trauma = Think PNE"
"Symmetric caudal + Asymmetric cranial = Classic PNE"